Monsanto Company has acquired Divergence, Inc., a privately-held St. Louis-based biotechnology research and development company. Divergence's current focus is its work with parasitic nematodes, including developing biotechnology traits for nematode control and nematicides with novel modes of action and superior safety profiles.
Divergence and Monsanto established a collaborative relationship in August 2004 under which the two companies worked to develop nematode-resistant soybeans. In 2008, the companies made public their sequence of the soybean cyst nematode genome, and extended their relationship.
Monsanto's chief technology officer, Robb Fraley, says nematodes are one of the most challenging agricultural pests costing farmers millions in damages annually to crops like corn, soy, cotton and vegetables.
Derek Rapp, Divergence's chief executive officer says they are thrilled to see their research and product platforms move to Monsanto, a company that has the experience and resources to deliver outstanding products to farmers.